ETF Home ETF List Shorted Stocks Home About

Portfolio Holdings Detail for ISIN IE00B3VWM098
Stock Name / FundiShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
IssuerBlackrock
Entity holding fund iShares VII Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300Q7FFITMZ2PFZ28
ETF TickerCUS1(GBX) LSE
ETF TickerCUSS(USD) LSE
ETF TickerSXRG(EUR) F
ETF TickerCSUSS.MI(EUR) CXE
ETF TickerCSUSSz(USD) CXE
ETF TickerCUSS.LS(USD) CXE
ETF TickerCSUSS(EUR) ETF Plus
ETF TickerCUS1.L(GBP) LSE
ETF TickerCUSS.L(GBP) LSE

Holdings detail for LGND

Stock NameLigand Pharmaceuticals Incorporated
TickerLGND(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS53220K5048
LEI5493008K7TB0IKP37H79

Show aggregate LGND holdings

News associated with LGND

Fidelity MSCI Health Care Index ETF -- Insider Buying Index Registering 19.3%
A look at the weighted underlying holdings of the Fidelity MSCI Health Care Index ETF (Symbol: FHLC) shows an impressive 19.3% of holdings on a weighted basis have experienced insider buying within the past six months. Illumina Inc (Symbol: ILMN), which makes up 0.27% of the F - 2025-09-09 10:54:08
Ligand Pharmaceuticals (NASDAQ:LGND) Given New $190.00 Price Target at Oppenheimer
Ligand Pharmaceuticals (NASDAQ:LGND – Get Free Report) had its price objective upped by Oppenheimer from $167.00 to $190.00 in a report released on Wednesday,Benzinga reports. The firm currently has an “outperform” rating on the biotechnology company’s stock. Oppenheimer’s target price points to a potential upside of 13.27% from the stock’s current price. A number of […] - 2025-09-05 05:03:20
Ligand Pharmaceuticals (NASDAQ:LGND) Sets New 52-Week High After Analyst Upgrade
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND – Get Free Report)’s stock price hit a new 52-week high during mid-day trading on Thursday after Oppenheimer raised their price target on the stock from $167.00 to $190.00. Oppenheimer currently has an outperform rating on the stock. Ligand Pharmaceuticals traded as high as $166.99 and last traded at $166.54, with […] - 2025-09-04 02:18:55
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Receives $157.00 Consensus Price Target from Brokerages
Shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND – Get Free Report) have earned a consensus recommendation of “Buy” from the six brokerages that are currently covering the company, Marketbeat reports. Six analysts have rated the stock with a buy recommendation. The average 1 year price objective among brokerages that have covered the stock in the last […] - 2025-08-27 02:07:03
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Position Lowered by Maryland State Retirement & Pension System
Maryland State Retirement & Pension System decreased its stake in shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND – Free Report) by 13.3% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The fund owned 5,519 shares of the biotechnology company’s stock after selling 844 shares during the period. Maryland State […] - 2025-08-15 04:50:59
Mutual of America Capital Management LLC Reduces Holdings in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND)
Mutual of America Capital Management LLC lowered its holdings in shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND – Free Report) by 3.8% in the first quarter, HoldingsChannel.com reports. The fund owned 2,752 shares of the biotechnology company’s stock after selling 110 shares during the quarter. Mutual of America Capital Management LLC’s holdings in Ligand Pharmaceuticals were […] - 2025-08-13 06:48:50
Deutsche Bank AG Sells 1,087 Shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND)
Deutsche Bank AG decreased its holdings in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND – Free Report) by 0.4% in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 287,965 shares of the biotechnology company’s stock after selling 1,087 shares during the quarter. Deutsche Bank AG owned 1.49% […] - 2025-08-13 05:19:03
Ligand Pharmaceuticals (NASDAQ:LGND) Stock Rating Upgraded by Wall Street Zen
Wall Street Zen upgraded shares of Ligand Pharmaceuticals (NASDAQ:LGND – Free Report) from a hold rating to a buy rating in a report published on Saturday. Several other analysts have also weighed in on LGND. Royal Bank Of Canada raised their price objective on Ligand Pharmaceuticals from $155.00 to $185.00 and gave the company an […] - 2025-08-12 04:12:53
Ligand Pharma Proposes Private Offering Of $400 Mln Of Sr. Notes
(RTTNews) - Ligand Pharmaceuticals Incorporated (LGND) Monday said it intends to privately offer $400 million of senior notes due 2030. - 2025-08-11 08:37:20
LGND Crosses Above Average Analyst Target
In recent trading, shares of Ligand Pharmaceuticals Inc (Symbol: LGND) have crossed above the average analyst 12-month target price of $144.75, changing hands for $146.32/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: down - 2025-08-08 08:32:29
Insiders Buy the Holdings of TECB ETF
A look at the weighted underlying holdings of the iShares U.S. Tech Breakthrough Multisector ETF (TECB) shows an impressive 14.6% of holdings on a weighted basis have experienced insider buying within the past six months. Ligand Pharmaceuticals Inc (Symbol: LGND), which makes - 2025-07-29 10:45:36
Victory Capital Management Inc. Purchases 13,456 Shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND)
Victory Capital Management Inc. lifted its position in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND – Free Report) by 94.6% in the 1st quarter, Holdings Channel.com reports. The institutional investor owned 27,678 shares of the biotechnology company’s stock after acquiring an additional 13,456 shares during the period. Victory Capital Management Inc.’s holdings in Ligand Pharmaceuticals were worth $2,910,000 […] - 2025-07-29 04:23:02
Mutual of America Capital Management LLC Cuts Stake in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND)
Mutual of America Capital Management LLC cut its holdings in shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND – Free Report) by 3.8% during the first quarter, HoldingsChannel.com reports. The fund owned 2,752 shares of the biotechnology company’s stock after selling 110 shares during the period. Mutual of America Capital Management LLC’s holdings in Ligand Pharmaceuticals were […] - 2025-07-24 04:37:00
Arizona State Retirement System Acquires 110 Shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND)
Arizona State Retirement System raised its position in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND – Free Report) by 2.1% in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 5,407 shares of the biotechnology company’s stock after acquiring an additional 110 shares during the […] - 2025-07-22 07:06:52
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Director Sells $116,750.00 in Stock
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND – Get Free Report) Director John W. Kozarich sold 934 shares of Ligand Pharmaceuticals stock in a transaction dated Thursday, July 10th. The shares were sold at an average price of $125.00, for a total value of $116,750.00. Following the transaction, the director owned 46,456 shares of the company’s stock, valued […] - 2025-07-14 05:38:47
Oregon Public Employees Retirement Fund Cuts Stake in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND)
Oregon Public Employees Retirement Fund trimmed its position in shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND – Free Report) by 2.3% during the 1st quarter, according to its most recent 13F filing with the SEC. The fund owned 4,342 shares of the biotechnology company’s stock after selling 100 shares during the quarter. Oregon Public Employees Retirement […] - 2025-07-09 05:43:24
Allspring Global Investments Holdings LLC Has $10.14 Million Holdings in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND)
Allspring Global Investments Holdings LLC decreased its holdings in shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND – Free Report) by 3.6% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 96,419 shares of the biotechnology company’s stock after selling 3,643 shares during the quarter. Allspring Global […] - 2025-07-04 05:06:54
Illinois Municipal Retirement Fund Increases Stake in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND)
Illinois Municipal Retirement Fund increased its holdings in shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND – Free Report) by 9.2% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 10,725 shares of the biotechnology company’s stock after purchasing an additional 902 […] - 2025-07-02 05:28:54
State of Alaska Department of Revenue Sells 269 Shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND)
State of Alaska Department of Revenue decreased its holdings in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND – Free Report) by 2.5% in the first quarter, HoldingsChannel.com reports. The institutional investor owned 10,470 shares of the biotechnology company’s stock after selling 269 shares during the quarter. State of Alaska Department of Revenue’s holdings in Ligand Pharmaceuticals were worth […] - 2025-06-26 04:44:48
10.2% of VTWV Holdings Seeing Recent Insider Buys
A look at the weighted underlying holdings of the Vanguard Russell 2000 Value (VTWV) shows an impressive 10.2% of holdings on a weighted basis have experienced insider buying within the past six months. NBT Bancorp. Inc. (Symbol: NBTB), which makes up 0.17% of the Vanguard Rus - 2025-06-23 10:36:21
Opal Wealth Advisors LLC Purchases Shares of 305 Ligand Pharmaceuticals Incorporated (NASDAQ:LGND)
Opal Wealth Advisors LLC purchased a new stake in shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND – Free Report) in the first quarter, according to the company in its most recent filing with the SEC. The fund purchased 305 shares of the biotechnology company’s stock, valued at approximately $32,000. A number of other hedge funds have […] - 2025-06-17 04:58:58
Handelsbanken Fonder AB Has $700,000 Stock Holdings in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND)
Handelsbanken Fonder AB raised its position in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND – Free Report) by 13.7% during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 6,658 shares of the biotechnology company’s stock after buying an additional 800 shares during […] - 2025-06-16 05:01:01
Rhumbline Advisers Trims Position in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND)
Rhumbline Advisers cut its holdings in shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND – Free Report) by 3.3% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The firm owned 57,456 shares of the biotechnology company’s stock after selling 1,989 shares during the period. Rhumbline Advisers’ holdings in Ligand Pharmaceuticals […] - 2025-06-13 04:36:56
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Receives $146.14 Average Price Target from Analysts
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND – Get Free Report) has earned a consensus recommendation of “Buy” from the seven ratings firms that are currently covering the firm, Marketbeat.com reports. Seven equities research analysts have rated the stock with a buy recommendation. The average twelve-month target price among brokers that have updated their coverage on the stock […] - 2025-06-13 02:32:49
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Acquires 10,563 Shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND)
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its holdings in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND – Free Report) by 26.5% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 50,401 shares of the biotechnology company’s stock after […] - 2025-06-03 05:13:09
Squarepoint Ops LLC Acquires Shares of 16,799 Ligand Pharmaceuticals Incorporated (NASDAQ:LGND)
Squarepoint Ops LLC acquired a new stake in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND – Free Report) during the fourth quarter, HoldingsChannel reports. The fund acquired 16,799 shares of the biotechnology company’s stock, valued at approximately $1,800,000. Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Smartleaf Asset Management […] - 2025-05-30 06:09:00
Bank of America Corp DE Has $11.51 Million Stock Holdings in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND)
Bank of America Corp DE lifted its stake in shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND – Free Report) by 2.4% in the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 107,439 shares of the biotechnology company’s stock after buying an additional 2,533 shares during the quarter. Bank of America Corp DE’s holdings in Ligand Pharmaceuticals […] - 2025-05-23 04:36:48
Jane Street Group LLC Sells 1,083 Shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND)
Jane Street Group LLC reduced its position in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND – Free Report) by 7.5% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 13,369 shares of the biotechnology company’s stock after selling 1,083 shares during the quarter. Jane Street Group LLC’s […] - 2025-05-20 04:30:46
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Receives $146.14 Consensus Target Price from Analysts
Shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND – Get Free Report) have earned an average recommendation of “Buy” from the seven ratings firms that are presently covering the company, MarketBeat reports. Seven analysts have rated the stock with a buy rating. The average 1-year price objective among analysts that have updated their coverage on the stock […] - 2025-05-19 02:14:54
The Manufacturers Life Insurance Company Increases Holdings in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND)
The Manufacturers Life Insurance Company increased its position in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND – Free Report) by 9.1% during the 4th quarter, Holdings Channel reports. The firm owned 9,373 shares of the biotechnology company’s stock after acquiring an additional 779 shares during the quarter. The Manufacturers Life Insurance Company’s holdings in Ligand Pharmaceuticals were worth […] - 2025-05-14 05:10:50

iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc LGND holdings

DateNumber of LGND Shares HeldBase Market Value of LGND SharesLocal Market Value of LGND SharesChange in LGND Shares HeldChange in LGND Base ValueCurrent Price per LGND Share HeldPrevious Price per LGND Share Held
2026-01-15 (Thursday)2,534LGND holding increased by 364USD 496,867LGND holding increased by 70375USD 496,867364USD 70,375 USD 196.08 USD 196.54
2026-01-14 (Wednesday)2,170LGND holding increased by 7USD 426,492LGND holding increased by 18161USD 426,4927USD 18,161 USD 196.54 USD 188.78
2026-01-13 (Tuesday)2,163USD 408,331LGND holding decreased by -38999USD 408,3310USD -38,999 USD 188.78 USD 206.81
2026-01-12 (Monday)2,163USD 447,330LGND holding increased by 346USD 447,3300USD 346 USD 206.81 USD 206.65
2026-01-09 (Friday)2,163USD 446,984LGND holding increased by 14243USD 446,9840USD 14,243 USD 206.65 USD 200.065
2026-01-08 (Thursday)2,163LGND holding increased by 7USD 432,741LGND holding increased by 1627USD 432,7417USD 1,627 USD 200.065 USD 199.96
2026-01-07 (Wednesday)2,156USD 431,114LGND holding increased by 8495USD 431,1140USD 8,495 USD 199.96 USD 196.02
2026-01-06 (Tuesday)2,156USD 422,619LGND holding increased by 8602USD 422,6190USD 8,602 USD 196.02 USD 192.03
2026-01-05 (Monday)2,156USD 414,017LGND holding increased by 4140USD 414,0170USD 4,140 USD 192.03 USD 190.11
2026-01-02 (Friday)2,156USD 409,877LGND holding increased by 2242USD 409,8770USD 2,242 USD 190.11 USD 189.07
2025-12-31 (Wednesday)2,156USD 407,635LGND holding decreased by -2436USD 407,6350USD -2,436 USD 189.07 USD 190.2
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of LGND by Blackrock for IE00B3VWM098

Show aggregate share trades of LGND

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2026-01-15BUY364199.350190.980 191.817USD 69,821 137.32
2026-01-14BUY7197.490186.262 187.385USD 1,312 137.08
2026-01-08BUY7204.860197.040 197.822USD 1,385 136.01
2025-12-23SELL-7202.270196.230 196.834USD -1,378 133.44 Loss of -444 on sale
2025-12-03SELL-35196.940191.266 191.833USD -6,714 129.67 Loss of -2,176 on sale
2025-12-02BUY14201.490194.240 194.965USD 2,730 129.36
2025-11-25SELL-21208.550202.530 203.132USD -4,266 127.58 Loss of -1,587 on sale
2025-11-24SELL-21207.020199.180 199.964USD -4,199 127.19 Loss of -1,528 on sale
2025-11-17SELL-77207.320200.824 201.473USD -15,513 125.32 Loss of -5,864 on sale
2025-11-12SELL-7209.990201.540 202.385USD -1,417 124.15 Loss of -548 on sale
2025-11-06SELL-7211.915186.960 189.456USD -1,326 122.44 Loss of -469 on sale
2025-11-05SELL-70193.070187.910 188.426USD -13,190 122.09 Loss of -4,644 on sale
2025-11-04SELL-14191.455186.280 186.797USD -2,615 121.73 Loss of -911 on sale
2025-11-03SELL-14193.020183.910 184.821USD -2,587 121.37 Loss of -888 on sale
2025-10-28BUY21188.870194.440 193.883USD 4,072 119.95
2025-10-24SELL-7186.980189.600 189.338USD -1,325 119.21 Loss of -491 on sale
2025-10-15BUY42183.300185.700 185.460USD 7,789 116.65
2025-10-02BUY7180.120182.650 182.397USD 1,277 115.92
2025-09-30BUY14177.140177.810 177.743USD 2,488 115.21
2025-09-17BUY647165.410169.230 168.848USD 109,245 113.95
2025-09-11BUY20167.060169.000 168.806USD 3,376 113.63
2025-08-21SELL-5157.310157.910 157.850USD -789 113.37 Loss of -222 on sale
2025-07-31BUY15131.580137.250 136.683USD 2,050 113.01
2025-06-30SELL-10113.680115.380 115.210USD -1,152 111.39 Loss of -38 on sale
2025-06-25SELL-5115.720118.250 117.997USD -590 111.31 Loss of -33 on sale
2025-06-20SELL-10114.070114.940 114.853USD -1,149 111.22 Loss of -36 on sale
2025-05-23BUY5101.600102.110 102.059USD 510 111.85
2025-05-19SELL-5105.310105.420 105.409USD -527 112.13 Profit of 34 on sale
2025-05-15SELL-15103.470105.400 105.207USD -1,578 112.27 Profit of 106 on sale
2025-05-12SELL-5106.380109.200 108.918USD -545 112.45 Profit of 18 on sale
2025-05-09SELL-5104.480107.150 106.883USD -534 112.52 Profit of 28 on sale
2025-04-30SELL-5109.860111.480 111.318USD -557 112.92 Profit of 8 on sale
2025-04-24SELL-10108.550109.240 109.171USD -1,092 113.07 Profit of 39 on sale
2025-04-17SELL-5104.970106.000 105.897USD -529 113.47 Profit of 38 on sale
2025-04-15SELL-15106.800107.270 107.223USD -1,608 113.64 Profit of 96 on sale
2025-04-14SELL-15106.590107.620 107.517USD -1,613 113.71 Profit of 93 on sale
2025-04-09SELL-20103.850106.350 106.100USD -2,122 114.07 Profit of 159 on sale
2025-04-07SELL-3599.410102.550 102.236USD -3,578 114.44 Profit of 427 on sale
2025-04-04SELL-5099.570101.150 100.992USD -5,050 114.61 Profit of 681 on sale
2025-03-31BUY5105.140106.370 106.247USD 531 114.92
2025-03-19SELL-10108.030109.080 108.975USD -1,090 115.54 Profit of 66 on sale
2025-03-14SELL-30106.190109.250 108.944USD -3,268 115.88 Profit of 208 on sale
2025-03-13SELL-10105.620109.270 108.905USD -1,089 116.02 Profit of 71 on sale
2025-03-12SELL-170108.090111.220 110.907USD -18,854 116.14 Profit of 889 on sale
2025-03-07SELL-10114.830117.100 116.873USD -1,169 116.41 Loss of -5 on sale
2025-03-06SELL-15116.000116.650 116.585USD -1,749 116.42 Loss of -2 on sale
2025-03-03SELL-5112.180125.170 123.871USD -619 116.52 Loss of -37 on sale
2025-02-28SELL-30122.230122.240 122.239USD -3,667 116.43 Loss of -174 on sale
2025-02-26SELL-5115.010120.720 120.149USD -601 116.46 Loss of -18 on sale
2025-02-25SELL-15118.700119.590 119.501USD -1,793 116.43 Loss of -46 on sale
2025-02-18BUY25119.990121.650 121.484USD 3,037 115.95
2025-02-13BUY5113.930115.990 115.784USD 579 115.83
2025-02-12BUY5111.390112.660 112.533USD 563 115.92
2025-02-11BUY15112.770114.750 114.552USD 1,718 115.99
2025-02-06BUY45117.840119.260 119.118USD 5,360 116.00
2025-01-27BUY5117.280119.110 118.927USD 595 115.71
2024-12-30BUY25105.760109.460 109.090USD 2,727 116.27
2024-12-06BUY20124.830127.860 127.557USD 2,551 115.90
2024-12-05BUY5123.510124.240 124.167USD 621 115.64
2024-12-04BUY25120.980123.000 122.798USD 3,070 115.45
2024-11-29BUY25121.470124.340 124.053USD 3,101 114.74
2024-11-27BUY20122.550125.000 124.755USD 2,495 114.06
2024-11-26BUY5124.330124.440 124.429USD 622 113.59
2024-11-21BUY25116.550118.120 117.963USD 2,949 112.77
2024-11-20BUY15111.560112.000 111.956USD 1,679 112.84
2024-11-18BUY60111.670113.040 112.903USD 6,774 112.97
2024-11-12BUY40120.740124.460 124.088USD 4,964 112.46
2024-11-08BUY25121.250127.260 126.659USD 3,166 111.83
2024-11-07BUY75129.900129.900 129.900USD 9,742 110.44
2024-11-06BUY10116.900116.950 116.945USD 1,169 109.90
2024-10-31BUY5105.700109.560 109.174USD 546 110.21
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of LGND

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19110,9840159,90369.4%
2025-09-18117,05413,457140,91383.1%
2025-09-1781,0050103,21478.5%
2025-09-1692,6970112,56582.3%
2025-09-1586,01012107,58079.9%
2025-09-1268,2880104,61565.3%
2025-09-1160,50930171,15985.0%
2025-09-1035,59322359,63359.7%
2025-09-09101,28228,400147,52068.7%
2025-09-0832,301042,92875.2%
2025-09-0572,28925,65990,82479.6%
2025-09-0434,07129039,29286.7%
2025-09-0355,9813,08464,95386.2%
2025-09-0233,2981,24754,73260.8%
2025-08-2949,3781,32460,18382.0%
2025-08-2841,1001,12250,66881.1%
2025-08-2742,61253353,75479.3%
2025-08-2630,55416,90544,55668.6%
2025-08-2552,52922657,73691.0%
2025-08-2279,21727,20096,31882.2%
2025-08-2126,4937334,68176.4%
2025-08-2034,99510048,39872.3%
2025-08-1934,4241,31446,47874.1%
2025-08-1857,7734,41284,24668.6%
2025-08-15110,17626,500135,28481.4%
2025-08-1488,17529,505111,16279.3%
2025-08-13106,25111,400149,50271.1%
2025-08-121,046,591263,2751,291,16781.1%
2025-08-11379,9690465,62381.6%
2025-08-0843,7041,58996,37045.4%
2025-08-0796,7527,844131,27573.7%
2025-08-0681,719098,01783.4%
2025-08-0531,9152,29155,50657.5%
2025-08-0427,4753,50042,04065.4%
2025-08-0143,001053,66080.1%
2025-07-3158,147089,22465.2%
2025-07-3044,7846,20772,41061.8%
2025-07-2926,036034,47875.5%
2025-07-2821,43093337,71756.8%
2025-07-2531,56687541,56076.0%
2025-07-2421,5771,18336,71758.8%
2025-07-2341,0436,12351,66379.4%
2025-07-2269,0811,50490,34476.5%
2025-07-21139,7546,798166,00384.2%
2025-07-1877,8828,200132,44158.8%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Copyright Market Footprint Ltd. Privacy Policy